COVID-19 Infection Prevention and Control Guidance Development Group
The World Health Organization (WHO) is continuously reviewing the available scientific data on infection prevention and control practices on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of Coronavirus Disease 2019 (COVID-19). WHO engages experts as members of Guideline Development Groups from a variety of specialties and across all regions to support the development of the Infection Prevention and Control guidance for COVID-19.
Members
Dr Babatunde Adebola Aiyelabola
Policy Officer, Health and Social Services Sector
Dr Yewanda Alimi
Antimicrobial Resistance (AMR) and One Health Program Coordinator
Dr Jameela Al Salman
Chairperson of Infection Control
Professor Anucha Apisarnthanarak
Professor Infectious Disease Consultant/Hospital Epidemiology
Professor Roger Chou
Associate Professor of Medicine
Dr May C. Chu
Clinical Professor and Senior Investigator
Dr John Conly
Professor of Medicine
Barry David Cookson
Honorary Professor in Medical Microbiology
Professor Dale Fisher
Professor of Medicine, Yong Loo Lin School of Medicine, NUS, Group Chief of Medicine, National University Health System (NUHS)
Dr Joost Hopman
Medical Director and Clinical Microbiologist
Dr Kushlani Jayatilleke
Consultant Microbiologist
Professor Souha Kanj
Professor of Medicine
Professor Daniele Lantagne
Professor in Civil and Environmental Engineering
Professor Anna Levin
Professor of Infectious Diseases*, Director of Division of Infectious Diseases#, President of the Infection Control Committee#
Professor Yuguo Li
Chair Professor
Dr Moi Lin Ling
Director, Infection Prevention & Epidemiology
Dr Mohammad Mushtuq Husain
Advisor
Professor Nizam Damani
Advisor to the Southern Trust, United Kingdom
Dr Tochi Okwor
Programme Coordinator, Antimicrobial Resistance and Infection Prevention & Control
Dr Hanene Tiouiri Benaissa
Head of the Infectious Diseases Department, University Hospital Rabta of Tunis, Tunisia
Dr Caline Mattar
Assistant Professor of Medicine
Professor Mary-Louise McLaws
Professor of Epidemiology, Honorary clinical Epidemiology and Member NSW Clinical Excellence Commission Taskforce for COVID-19
Dr Geeta Mehta
Independent Consultant and Advisor
Professor Shaheen Mehtar
Retired Professor of IPC and Chair Education Committee ICAN
Ziad Memish
Infectious Disease Consultant and Director, Research Centre, King Saud Medical City, Ministry of Health Kingdom of Saudi Arabia
Dr Mauro Orsini
Coordinator of the National Healthcare Related Infection Prevention and Control (HRIPC) Program
Dr Diamantis Plachouras
Principal expert antimicrobial resistance and healthcare-associated infections
Dr Mathias Pletz
Professor and Chair
Professor Marina Salvadori
Professor in the Division of Pediatric Infectious Diseases
Dr Ingrid Schoeman
Director of Advocacy and Strategy
Dr Mitchell Schwaber
Director
Professor Wing Hong Seto
Co-Director
Dr Mark Sobsey
Research Professor
Professor Paul Ananth Tambyah
Professor of Medicine, National University of Singapore, Senior Consultant ID Physician National University Hospital, Visiting Consultant, National Center for Infectious Diseases, Ng Teng Fong General Hospital, Singapore Armed Forces
Professor Andreas Voss
Professor of Infection Control
Dr Walter Zingg
Charité Universitätsmedizin
Temporary Advisors
Dr Fernanda C. Lessa
Lead, Prevention Team HAI, and AMR
Contact
Please send any comments to [email protected] with the following text in the subject line: Public Comment: WHO Health Emergencies
Programme COVID-19 infection prevention and control Guidance Development Group.